Latest filing published 22 Aug 2007 for Ernexa Therapeutics Inc., €17k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -67.0%Entry US$682,500.00 · Close at T+365 US$225,000.00
- -27.3%Entry US$960,000.00 · Close at T+365 US$697,500.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Dario Loreto Santana: trading record in brief
All filings by Dario Loreto Santana on record concern Ernexa Therapeutics Inc. In total, 2 filings cover trades dated from 25 August 2006 to 20 August 2007.
On the market, this insider has only ever bought: 2 purchases, €63k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2007 to date brings 1 purchase and no sales.
The latest filing, published on 22 August 2007, reports an open-market purchase of €17k in Ernexa Therapeutics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dario Loreto Santana
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$0.8998Common StockSEC:0001181431-07-053597:0Canonical exit: 18 Nov 2007 (T+90)
- 50,000 shares@ US$1.19Common StockSEC:0001181431-06-050127:0Canonical exit: 23 Nov 2006 (T+90)
2 of 2 declarations
